Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction
PHASE2
To evaluate the efficacy and safety of liposome irinotecan combined with pl...
Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction
PHASE4
To evaluate the efficacy and safety of liposome irinotecan combined with pl...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of China Medical University